KEY FEATURES
Full Name | Bone Morphogenetic Protein 1 |
---|---|
Synonym | PCOLC; PCP; TLD; mTld; Procollagen C Proteinase; Mammalian tolloid protein |
Assay Type | Sandwich |
Reactivity | Human |
Range | 15.6-1000pg/mL |
Sensitivity | 6.3pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human BMP1 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human BMP1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human BMP1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human BMP1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human BMP1. You can calculate the concentration of Human BMP1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human BMP1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 48.47 | 88.22 | 347.84 | 46.58 | 81.15 | 315.49 |
Standard deviation | 3.04 | 5.09 | 11.62 | 3.25 | 4.38 | 16.53 |
CV(%) | 6.27 | 5.77 | 3.34 | 6.97 | 5.4 | 5.24 |
RECOVERY
The recovery of Human BMP1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 87-100 | 92 |
EDTA plasma (n=8) | 95-112 | 102 |
Cell culture media (n=8) | 85-98 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human BMP1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with PCP ELISA Kits
LOX ELISA Kit | publications with PCP and LOX |
PRL ELISA Kit | publications with PCP and PRL |
ADAMTS2 ELISA Kit | publications with PCP and ADAMTS2 |
COL7A1 ELISA Kit | publications with PCP and COL7A1 |
LAMC2 ELISA Kit | publications with PCP and LAMC2 |
CHRD ELISA Kit | publications with PCP and CHRD |
Pathways associated with PCP ELISA Kit
Adipogenesis Pathway | Adipogenesis Pathway |
Anchoring Fibril Formation Pathway | Anchoring Fibril Formation Pathway |
Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway | Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway |
Cardiac Progenitor Differentiation Pathway | Cardiac Progenitor Differentiation Pathway |
Collagen Biosynthesis And Modifying Enzymes Pathway | Collagen Biosynthesis And Modifying Enzymes Pathway |
Collagen Formation Pathway | Collagen Formation Pathway |
Crosslinking Of Collagen Fibrils Pathway | Crosslinking Of Collagen Fibrils Pathway |
Degradation Of The Extracellular Matrix Pathway | Degradation Of The Extracellular Matrix Pathway |
Extracellular Matrix Organization Pathway | Extracellular Matrix Organization Pathway |
HDL-mediated Lipid Transport Pathway | HDL-mediated Lipid Transport Pathway |
Diseases associated with PCP ELISA Kit
Fibrosis | publications with PCP and Fibrosis |
Nervous System Diseases | publications with PCP and Nervous System Diseases |
Neoplasm Metastasis | publications with PCP and Neoplasm Metastasis |
Inflammation | publications with PCP and Inflammation |
Breast Neoplasms | publications with PCP and Breast Neoplasms |
Kidney Diseases | publications with PCP and Kidney Diseases |
Myocardial Infarction | publications with PCP and Myocardial Infarction |
Necrosis | publications with PCP and Necrosis |
Lung Neoplasms | publications with PCP and Lung Neoplasms |
Neoplasms, Experimental | publications with PCP and Neoplasms, Experimental |
Organs/Tissues associated with PCP ELISA Kit
Bone | publications with PCP and Bone |
Connective Tissue | publications with PCP and Connective Tissue |
Embryonic Tissue | publications with PCP and Embryonic Tissue |
Muscle | publications with PCP and Muscle |
Vascular | publications with PCP and Vascular |
Kidney | publications with PCP and Kidney |
Heart | publications with PCP and Heart |
Bone Marrow | publications with PCP and Bone Marrow |
Skin | publications with PCP and Skin |
Eye | publications with PCP and Eye |